Smith & Nephew PLC

Here is the public summary page for Smith & Nephew PLC. Please login to see the complete information for Smith & Nephew PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Smith & Nephew PLC stacks up relative to its peers.


Darwin Score+21
TickerSN.
Latest Price11.71 GBP as of close on 28-Jul-2025
3 Month price range9.38 to 11.25 GBP
Market Capitalisation9.71Bn GBP
CountryUnited Great Britain and Northern Ireland
RegionEurope
Economic SectorHealth Care
Business SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryHealth Care Equipment
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
See More ...
Company URLhttps://www.smith-nephew.com
See Darwins Full Analysis for Smith & Nephew PLC

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Smith & Nephew PLC. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+19
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.+9
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-8

Peer Comparison

There is 1 peer of Smith & Nephew PLC.
Asset NameIndustry GroupPerf(20d)%Asset Score
Surgical Innovations Group PLC (SUN)Health Care Equipment0-2

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn